drugset
drugset / Trial / NCT04206020

Vehicle-Controlled Study of SkQ1 as Treatment for Dry-eye Syndrome

NCT04206020 ↗

Phase 3 Completed 610 enrolled Mitotech, SA ORA, Inc. · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate whether SkQ1 Ophthalmic Solution is safe and effective compared to Vehicle for the treatment of the signs and symptoms of dry eye syndrome.

Timeline

Start
2019-12-20
Primary completion
2020-10-06
Completion
2020-10-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator SkQ1 Other / unclassified — Other

Indications

dry eye syndrome